Technology
Health
Biotechnology

Armata Pharmaceuticals

$4.00
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.30 (8.11%) Today
$0.00 (0.00%) As of 4:00 PM EDT after-hours

Why Robinhood?

You can buy or sell ARMP and other stocks, options, ETFs, and crypto commission-free!

About ARMP

Armata Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company focused on the development of bacteriophage therapeutics for antibiotic-resistant infections using its proprietary bacteriophage-based technology. Its product candidate is the AP-SA01 that targets Staphylococcus aureus, including multidrug-resistant strains. Read More The company was founded on May 9, 2019 and is headquartered in Los Angeles, CA.

Employees
31
Headquarters
Los Angeles, California
Founded
2019
Market Cap
39.84M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
16.44K
High Today
$4.10
Low Today
$3.86
Open Price
$3.89
Volume
25.31K
52 Week High
$19.18
52 Week Low
$2.15

Collections

Technology
Health
Biotechnology
Medical
Therapy
US
North America
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.